Skip to content

Modulation of Brain Oscillations Underlying Working Memory

State-dependent Modulation of Interactions of Theta and Gamma Rhythms in Working Memory

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05923606
Enrollment
32
Registered
2023-06-28
Start date
2024-07-10
Completion date
2027-03-31
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Working Memory

Keywords

Working memory, Attention, Theta oscillations, Transcranial Alternating Current Stimulation

Brief summary

This study will use novel transcranial alternating current stimulation (tACS) protocols and electroencephalography (EEG) to modulate and measure brain oscillations that underlie working memory. tACS is a noninvasive method used to modulate the timing and patterns of brain rhythms via weak electric currents passed through electrodes on the scalp.

Detailed description

In this study, healthy adult individuals will perform a spatial working memory task as investigators record scalp EEG before and immediately after undergoing transcranial alternating current stimulation (tACS). Each participant will complete four tACS sessions in randomized order: 1) theta-nested gamma tACS applied during active task periods, 2) theta-nested gamma tACS applied during passive (rest) periods, 3) gamma stimulation applied in phase with ongoing theta oscillations, and 4) placebo tACS. The different stimulation protocols will take place on different days. Therefore, participants will be expected to attend 4 in-person study visits at the Martinos Center for Biomedical Imaging in Charlestown, Massachusetts.

Interventions

Active tACS will be administered over the left dorsolateral prefrontal cortex for approximately 25 minutes.

DEVICEPlacebo tACS

Placebo tACS will be administered over the left dorsolateral prefrontal cortex for approximately 25 minutes.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Able to provide informed consent * Fluent in English.

Exclusion criteria

* History of a neurological/psychiatric disorder * Current use of psychotropic medications * Current use of substances and drugs that were shown to affect tES (transcranial electrical stimulation) efficacy (dopamine altering drugs, nicotine, NMDA (N-methyl-D-aspartate) antagonists/agonists, sodium/calcium channel blockers, norepinephrine reuptake inhibitors, GABAergic modulators and selective serotonin reuptake inhibitors) * Contraindications for tACS (e.g., history of seizures, metallic implants in the head or neck, implanted brain stimulators, vagus nerve stimulators, pacemakers, pregnancy)

Design outcomes

Primary

MeasureTime frameDescription
Working memory accuracy2 hoursAccuracy of working memory retrieval during a Delayed Match-to-Sample task will be assessed before and during tACS interventions
Working memory accuracy under interference2 hoursAccuracy of working memory retrieval during interference conditions of a Delayed Match-to-Sample task will be assessed before and during tACS interventions.
Theta-gamma cross-frequency coupling2 hoursCross-frequency coupling between theta band phase and gamma band amplitude will be calculated using the EEG data collected while subjects perform the Delayed Match-to-Sample task before and after tACS interventions.
Fronto-parietal theta phase synchronization2 hoursPhase synchronization in the theta band between frontal and parietal brain regions will be calculated using the EEG data collected while subjects perform the Delayed Match-to-Sample task before and after the tACS interventions.

Countries

United States

Contacts

CONTACTAllyson Smith, B.S.
asmith192@mgh.harvard.edu(617) 726-1040
CONTACTHamdi Eryilmaz, Ph.D.
hamdi.eryilmaz@mgh.harvard.edu(617) 643-7462
PRINCIPAL_INVESTIGATORHamdi Eryilmaz, Ph.D.

Massachusetts General Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026